Hanmi Pharm Co Ltd
KRX:128940
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
264 500
366 169.2238
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Hanmi Pharm Co Ltd
Hanmi Pharm Co Ltd
Other Long-Term Assets
Hanmi Pharm Co Ltd
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Other Long-Term Assets
₩158.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
22%
|
|
|
Yuhan Corp
KRX:000100
|
Other Long-Term Assets
₩109.2B
|
CAGR 3-Years
38%
|
CAGR 5-Years
30%
|
CAGR 10-Years
25%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Other Long-Term Assets
₩55.5B
|
CAGR 3-Years
55%
|
CAGR 5-Years
105%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Science Co Ltd
KRX:008930
|
Other Long-Term Assets
₩16B
|
CAGR 3-Years
2%
|
CAGR 5-Years
13%
|
CAGR 10-Years
35%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Other Long-Term Assets
₩11.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
27%
|
CAGR 10-Years
17%
|
|
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Other Long-Term Assets
₩13.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-6%
|
|
Hanmi Pharm Co Ltd
Glance View
Hanmi Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2010-07-30. The firm operates its business through three segments. The Pharmaceuticals segment manufactures and sells tablets, capsules, injections, syrups, powders and raw materials used in the treatment of hypertension, reflux esophagitis, influenza type A and influenza type B virus infections and hyperlipidemia, among others. The Other segment is engaged in the materials processing. The Export segment produces and sells products such as powders and injections, and exports technologies.
See Also
What is Hanmi Pharm Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
158.4B
KRW
Based on the financial report for Sep 30, 2024, Hanmi Pharm Co Ltd's Other Long-Term Assets amounts to 158.4B KRW.
What is Hanmi Pharm Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
22%
Over the last year, the Other Long-Term Assets growth was 6%. The average annual Other Long-Term Assets growth rates for Hanmi Pharm Co Ltd have been 5% over the past three years , 10% over the past five years , and 22% over the past ten years .
You don't have any saved screeners yet
